Russia’s Gamaleya National Research Center considers the possibility to develop polyvalent vaccines against a new coronavirus infection on the basis of various strains such as Delta and Omicron, deputy director of the Gamaleya National …
The European Medicines Agency (EMA) experts have positively evaluated production standards for Sputnik V COVID-19 vaccine, deputy head of the Gamaleya Research Centre Denis Logunov said on Tuesday. "Regarding how the production …
A dramatic growth in COVID-19 incidence is forecasted in Russia in late January - early February, deputy director of the Gamaleya National Research Center of Epidemiology and Microbiology, Denis Logunov, said on Tuesday. "I am …
The effectiveness of the Sputnik V vaccine against the Indian strain of the novel coronavirus is 2.6 times lower than against other varieties, deputy director of the Gamaleya Center Denis Logunov said on Tuesday, adding that the decline was not …
